Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Picks of the quarter -- Ignore unavailable to you. Want to Upgrade?

To: Elroy who wrote (3260)	4/18/2007 2:44:50 AM
From: Mike McFarland	Respond to of 20435

Thanks very much! ----- Somewhat off topic, your complete 20/20 hindsight bullshit article of the night: fool.com Ah, Vertex was a value stock! "Don't make the mistake of confusing growth investing with speculation" What horseshit, they are one and the same! Vertex and Genentech are indeed speculative stocks-- and only partly because they are so expensive now. And any number of smart startup biotechs could eat their lunch over the next ten years. I should short both of them in this contest if only to underscore my point that they are indeed speculative--and very likely to be volatile. Both could be down 50% a year from now. Lessee, what sacred cows have we seen in biotech: Amgen declined from $75 to $55 in a few short months, and you can be sure some folks bought their very first shares of Amgen near the high. And people will buy Vertex and Genentech near the high too--articles such as this might even goad them into doing it, pure twaddle.